[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

September 2023 | 37 pages | ID: A70B742D2B0EN
MarketLine

US$ 175.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Astex Pharmaceuticals, Inc. %li%Strategy, SWOT and Corporate Finance Report

Summary

Astex Pharmaceuticals, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Astex Pharmaceuticals, Inc. (Astex or ‘the company’), a member of Otsuka Group, discovers, develops and commercializes cancer and central nervous system (CNS) therapies. It offers oncology product portfolio with multiple drugs in mid-late stage clinical development worldwide and CNS product portfolio of novel targeted therapeutics for defined neurodegenerative disease populations. Its product pipeline includes), a next generation DNA-hypomethylating agent; ASTX727, TAS1553, TAS1440, Azacitidine and Cedazuridine (ASTX030), an oral DNMT (DNA methyltransferase) inhibitor; ASTX029, an inhibitor of ERK 1/2; and ASTX660, a dual IAP (inhibitors of apoptosis proteins) antagonist. Astex has business presence in the UK and the US. The company is headquartered in Pleasanton, California, the US.

Scope
  • Detailed information on Astex Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Astex Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Astex Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Astex Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Astex Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
  • Gain understanding of Astex Pharmaceuticals, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Astex Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Astex Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Company Snapshot
Astex Pharmaceuticals, Inc.: Company Overview
Astex Pharmaceuticals, Inc.: Overview and Key Facts
Astex Pharmaceuticals, Inc.: Overview
Astex Pharmaceuticals, Inc.: Key Facts
Astex Pharmaceuticals, Inc.: Key Employees
Astex Pharmaceuticals, Inc.: Key Employee Biographies
Astex Pharmaceuticals, Inc.: Major Products and Services
Astex Pharmaceuticals, Inc.: Company History
Astex Pharmaceuticals, Inc.: Management Statement
Astex Pharmaceuticals, Inc.: Locations and Subsidiaries
Astex Pharmaceuticals, Inc.: Key Competitors
Astex Pharmaceuticals, Inc.: Company Analysis
Astex Pharmaceuticals, Inc.: Business Description
Astex Pharmaceuticals, Inc.: SWOT Analysis
Astex Pharmaceuticals, Inc.: SWOT Overview
Astex Pharmaceuticals, Inc.: Strengths
Astex Pharmaceuticals, Inc.: Weaknesses
Astex Pharmaceuticals, Inc.: Opportunities
Astex Pharmaceuticals, Inc.: Threats
Astex Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Astex Pharmaceuticals, Inc.: Financial Deals Overview
Astex Pharmaceuticals, Inc.: Targets and Partners
Astex Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Astex Pharmaceuticals, Inc.: Partnership
Astex Pharmaceuticals, Inc.: Recent Developments
Astex Pharmaceuticals, Inc.: News and Events Summary
Astex Pharmaceuticals, Inc.: Corporate Governance
Astex Pharmaceuticals, Inc.: Financial Deals
Astex Pharmaceuticals, Inc.: Market Developments
Astex Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

LIST OF TABLES

Table 1: Astex Pharmaceuticals, Inc.: Key Facts
Table 2: Astex Pharmaceuticals, Inc.: Key Employees
Table 3: Astex Pharmaceuticals, Inc.: Company History
Table 4: Astex Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Astex Pharmaceuticals, Inc.: Key Competitors
Table 6: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Table 8: Astex Pharmaceuticals, Inc.: Targets and Partners
Table 9: Astex Pharmaceuticals, Inc.: Top Deals 2019 - 2023YTD*
Table 10: Astex Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Table 11: Astex Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)
Table 12: Astex Pharmaceuticals, Inc.: News and Events Summary
Table 13: Astex Pharmaceuticals, Inc.: Corporate Governance
Table 14: Astex Pharmaceuticals, Inc.: Financial Deals
Table 15: Astex Pharmaceuticals, Inc.: Market Developments
Table 16: Astex Pharmaceuticals, Inc.: Research & Development

LIST OF FIGURES

Figure 1: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Astex Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2019 - YTD*2023)
Figure 3: Astex Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2019 - YTD*2023)
Figure 4: Astex Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2019 - YTD*2023)


More Publications